[Anti-VGKC Complex Antibodies and Limbic Encephalitis].

Area of Science:

• Neurology
• Immunology
• Neuroimmunology

Background:

• Voltage-gated potassium channel (VGKC)-associated antibodies are primarily directed against LGI1 and CASPR2.
• Limbic encephalitis is a clinical syndrome often associated with these autoantibodies.
• The condition typically affects middle-aged adults, presenting with amnesia and seizures.

Purpose of the Study:

• To elucidate the clinical presentations and diagnostic significance of LGI1 and CASPR2 antibodies.
• To highlight the efficacy of immunotherapy in patients with VGKC-complex antibody-associated limbic encephalitis.
• To emphasize the importance of early autoantibody detection for accurate diagnosis and management.

Main Methods:

• Detection of LGI1 and CASPR2 antibodies using a cell-based assay.
• Clinical correlation of antibody status with patient symptoms and diagnosis.
• Assessment of treatment response to immunotherapy.

Main Results:

• Anti-LGI1 antibodies are associated with faciobrachial dystonic seizures.
• Anti-CASPR2 antibodies are linked to neuromyotonia.
• Both antibody-positive groups show significant improvement with immunotherapy, but amnesia can be long-lasting, and relapses may occur.

Conclusions:

• LGI1 and CASPR2 antibodies are key targets in limbic encephalitis.
• Early diagnosis through autoantibody testing is crucial, as symptoms can mimic degenerative dementia or chronic epilepsy.
• While immunotherapy is effective, long-term sequelae like persistent amnesia warrant further investigation and management strategies.